Table 3 Hazard ratios (HRs) of Herpes Zoster among heart failure patients during the 1-month, 6-month and 1-year follow-up period from the index ambulatory visits or inpatient care from 2001 to 2009
| Â | 1-month follow-up period | 6-month follow-up period | 1-year follow-up period | |||
|---|---|---|---|---|---|---|
Development of Herpes Zoster | Patients with heart failure | Comparison | Patients with heart failure | Comparison | Patients with heart failure | Comparison |
Yes (%) | 21 (0.4) | 18 (0.1) | 50 (1.0) | 62 (0.4) | 83 (1.7) | 128 (0.9) |
No (%) | 4764 (99.6) | 14337 (99.9) | 4735 (99.0) | 14293 (99.6) | 4702 (98.3) | 14227 (99.1) |
Crude HR (95% CI) | 3.51 (1.87-6.59)* | 1 | 2.44 (1.68-3.54)* | 1 | 1.96 (1.49-2.59)*** | 1 |
Adjusted HR (95% CI) | 4.52 (2.28-8.96)* | 1 | 2.67 (1.79-3.98)* | 1 | 2.07 (1.54-2.78)*** | 1 |